Atlas Trials

A Study of EDP-938 in Healthy Subjects

Clinical trial NCT03384823 · COMPLETED

Trial details

NCT number
NCT03384823
Sponsor
Enanta Pharmaceuticals, Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
RSV Infection
Start date
2017-12-07
Primary completion
2018-07-03
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.